Total planned funding: $783,599,582
Clear active filters
Partnership for Supply Chain Management
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Allocations
Countries/Regions
| Nigeria | $176,050,753 |
| Zambia | $94,743,463 |
| Mozambique | $78,872,898 |
| Tanzania | $73,350,040 |
| Ethiopia | $65,961,404 |
| Côte d'Ivoire | $50,734,633 |
| Haiti | $45,406,201 |
| Uganda | $44,513,957 |
| Rwanda | $40,807,411 |
| Zimbabwe | $28,435,920 |
| Vietnam | $17,268,197 |
| South Africa | $16,650,000 |
| Democratic Republic of the Congo | $10,505,204 |
| Kenya | $9,461,533 |
| Eswatini | $7,083,174 |
| Malawi | $6,695,287 |
| Namibia | $4,362,998 |
| Guyana | $4,325,357 |
| Botswana | $3,154,600 |
| Burundi | $2,113,926 |
| South Sudan | $1,527,626 |
| Burma | $1,075,000 |
| Central America Region | $500,000 |
| Cameroon | $0 |
| Ghana | $0 |
Organizational Types
| Private Contractor | $783,599,582 |
Program Areas
| Treatment | $581,608,152 |
| Governance and Systems | $77,506,931 |
| Care | $44,556,390 |
| Prevention | $39,635,132 |
| Testing | $39,192,977 |
| Management and Operations | $1,100,000 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $488,408,637 |
| HTXS: Treatment: Adult Treatment | $88,856,365 |
| HLAB: Laboratory Infrastructure | $44,108,887 |
| HVCT: Testing: HIV Testing and Counseling | $39,192,977 |
| HBHC: Care: Adult Care and Support | $32,362,718 |
| OHSS: Health Systems Strengthening | $27,984,625 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $23,571,687 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $8,679,399 |
| HVTB: Care: TB/HIV | $6,306,100 |
| HVSI: Strategic Information | $5,413,419 |
| PDCS: Care: Pediatric Care and Support | $5,127,762 |
| PDTX: Treatment: Pediatric Treatment | $4,343,150 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $4,195,798 |
| HMBL: Biomedical Prevention: Blood Safety | $2,600,000 |
| HVMS: Management and Operations | $1,100,000 |
| HKID: Care: Orphans and Vulnerable Children | $759,810 |
| HMIN: Biomedical Prevention: Injection Safety | $588,248 |